Ameritas Investment Partners’s Cytek Biosciences CTKB Stock Holding History

Ameritas Investment Partners’s Portfolio CTKB Stock Details CTKB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43.5K	Hold	9,823	–	–	﹤0.01%	2330
2026 Q1	$42.9K	Hold	9,823	–	–	﹤0.01%	2177
2025 Q4	$49.6K	Hold	9,823	–	–	﹤0.01%	2118
2025 Q3	$34.1K	Sell	9,823 -2,219	-18%	-$8.33K	﹤0.01%	2410
2025 Q2	$40.9K	Hold	12,042	–	–	﹤0.01%	2315
2025 Q1	$48.3K	Hold	12,042	–	–	﹤0.01%	2121
2024 Q4	$78.2K	Hold	12,042	–	–	﹤0.01%	1927
2024 Q3	$66.7K	Hold	12,042	–	–	﹤0.01%	2025
2024 Q2	$67.2K	Hold	12,042	–	–	﹤0.01%	1972
2024 Q1	$80.8K	Hold	12,042	–	–	﹤0.01%	1870
2023 Q4	$110K	Hold	12,042	–	–	﹤0.01%	1668
2023 Q3	$66.5K	Buy	12,042 +2,033	+20%	+$16.3K	﹤0.01%	1927
2023 Q2	$85.5K	Buy	10,009 +1,445	+17%	+$13K	﹤0.01%	1703
2023 Q1	$78.7K	Hold	8,564	–	–	﹤0.01%	1687
2022 Q4	$93.8K	Hold	8,564	–	–	﹤0.01%	1647
2022 Q3	$126K	Hold	8,564	–	–	0.01%	1333
2022 Q2	$91K	Buy	8,564 +997	+13%	+$9.92K	﹤0.01%	1577
2022 Q1	$82K	Buy	7,567 +6,336	+515%	+$85.6K	﹤0.01%	1763
2021 Q4	$20K	Hold	1,231	–	–	﹤0.01%	2640
2021 Q3	$26K	Buy	+1,231	New	+$29K	﹤0.01%	2554

Other funds holding CTKB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

TCM

Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ameritas Investment Partners's CTKB Position: Q2 2026 in Review

Ameritas Investment Partners held its Cytek Biosciences (CTKB) position steady in Q2 2026 at 9,823 shares worth $43.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2330.

Ameritas Investment Partners first reported a position in CTKB in Q3 2021 and has held it in 20 quarters since. The position peaked at $126K in Q3 2022. 154 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

Ameritas Investment Partners held 9,823 shares of Cytek Biosciences worth $43.5K as of Q2 2026.
Ameritas Investment Partners left its Cytek Biosciences share count unchanged in Q2 2026.
Cytek Biosciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2330 holding.
Ameritas Investment Partners first reported a position in Cytek Biosciences in Q3 2021 and has held it in 20 quarters since.
Ameritas Investment Partners's Cytek Biosciences position peaked at $126K in Q3 2022.
154 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.